The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Maintain Rheumatology’s Seat at the AMA Table

Maintain Rheumatology’s Seat at the AMA Table

May 9, 2012 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR needs a total of 1,000 AMA members to retain our seat in the American Medical Association Federation. Membership in the Federation allows the ACR to be represented in important decision-making bodies including the AMA House of Delegates and the AMA Relative Value Update Committee. The House of Delegates sets and adjusts the AMA’s legislative and regulatory agenda and provides opportunities to influence the direction of the AMA’s policy priorities. If rheumatology has no seat at the table, we have no influence on medicine’s public policy agenda. The AMA RUC advises the Center for Medicare and Medicaid Services on the value of billing codes. Having rheumatologists on this panel allows the presentation of information on codes relevant to rheumatology. With no seat at the AMA table, rheumatology would have no voice in physician-reimbursement discussions.

You Might Also Like
  • Why Keep a Seat at the AMA Table?
  • The ACR Maintains Seat at the AMA Table, Achieves Successful Resolutions at HOD Meeting
  • Pointers for Rheumatologists Considering AMA Membership
Explore This Issue
May 2012
Also By This Author
  • Pisetsky’s Rules vs. the Peltzman Effect

Your Action is Needed

Currently, the ACR has significantly fewer than the required 1,000 members needed to preserve our seat. Become a member of the AMA today to ensure that rheumatology retains a stake in policy and reimbursement discussions. You can join at www.ama-assn.org. When you join, please notify Tiffany Schmidt at [email protected] so that your membership is counted toward the required total.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Billing/Coding, From the College, Legislation & Advocacy, Practice Management, Professional Topics Tagged With: AC&R, Advocacy, AMA, American College of Rheumatology, Billing, Legislation, Medicare, Practice ManagementIssue: May 2012

You Might Also Like:
  • Why Keep a Seat at the AMA Table?
  • The ACR Maintains Seat at the AMA Table, Achieves Successful Resolutions at HOD Meeting
  • Pointers for Rheumatologists Considering AMA Membership
  • AMA House of Delegates Meeting: Decisions Affecting You

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.